The global market for corneal neovascularization is thriving due to the rapid developments in the field of ophthalmology. A report prepared by the researchers at Transparency Marker Research (TMR) explains the factors responsible for the growth of the global market for corneal neovascularization. The title of the report is ‘Corneal Neovascularization Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024’. Corneal neovascularization is an eye disorder characterized by the growth of abnormal blood vessels in the cornea that is naturally translucent and clear. The main reason behind the development of these blood vessels is oxygen deprivation and excessive stress. Long-term usage of contact lenses can also contribute to the development of corneal vascularization while trauma, chemical burns, and infections can immediately lead to the disorder. The blood vessels have a natural limit of 2mm to their distance from the corneal lining, and if that limit is crossed, there are high chances of corneal neovascularization. Multiple factors can cause corneal neovascularization because of which all the individuals are equally vulnerable to the disorder. Medical practitioners recommend people to take extra care while using chemical substances in order to prevent corneal neovascularization. People who wear contact lenses are required to regularly clean the lenses and consult their doctor with regards to the duration of time the lenses can be worn.
In recent times, the cases of hypertension have increased by a substantial number which has propelled demand within the global market for corneal neovascularization. The field of ophthalmology has undergone rapid changes which has led to the development of sophisticated treatments for eye disorders. This is also an important factor that contributes to the growth of the global market while providing lucrative opportunities to market players. It is an established fact that people pay immense attention to eye care, and are swift to consult a doctor for the mildest of uneasiness or discomfort felt in the eyes. Furthermore, the current scenario has witnessed an increase in the geriatric population along with a steep rise in the cases of obesity. Both of these factors contribute to the growth of the global market for corneal neovascularization. Besides this, a wide range of therapeutic drugs for the treatment of corneal neovascularization are in the pipeline.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17270
People across North America and Europe are aware of the healthcare treatments available in the market which plays to the advantage of the market. Moreover, the instance of ophthalmic disorders in these regions is higher relative to other regions. Hence, North America and Europe are projected to collectively hold a dominant market share over the coming years.
Some of the key players in the global market for corneal neovascularization are Amakem NV, Sirnaomics, Inc., and F. Hoffmann-La Roche Ltd., GTx, Inc.